| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.16B | -33.3% |
| Cost of Revenue | $1.52B | -39.3% |
| Gross Profit | $2.64B | -29.2% |
| R&D Expense | $259.2M | -37.4% |
| SG&A Expense | $1.66B | -23.5% |
| Operating Income | $720.2M | -40.3% |
| Interest Expense | -$120.5M | +21.1% |
| Pre-tax Income | $602.2M | -37.9% |
| Income Tax | $69.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $375.5M | -53.8% |
| Accounts Receivable | $683.6M | -27.7% |
| Inventory | $291.8M | -46.4% |
| Current Assets | $1.61B | -38.1% |
| Total Assets | $11.74B | -31.0% |
| Current Liabilities | $2.25B | +0.4% |
| Long-term Debt | $3.21B | -13.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.08B | -29.1% |
| Capital Expenditures | $105.1M | -12.7% |
| Investing Cash Flow | -$135.4M | +92.5% |
| Financing Cash Flow | -$1.39B | -74.9% |
| Free Cash Flow | $978.1M | -30.5% |
| -49.2% |
| Net Income | $579.2M | -30.5% |
| EPS (Basic) | $1.74 | -27.2% |
| EPS (Diluted) | $1.73 | -26.7% |
| Stockholders' Equity |
| $6.45B |
| -36.7% |